Related Experiment Video
Updated: Sep 21, 2026

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
Published on: May 7, 2012
Dynamically Expressed miR-BART16 Functions as a Suppressor of CAND1 in Infectious Mononucleosis Caused by
Zhenhua Hu1, Xiuxiu Zheng2, Wanjie Zeng1
1Department of Clinical Laboratory, Suzhou Kowloon Hospital, Shanghai Jiaotong University School of Medicine, Suzhou, China.
Objective:
MiR-BART16 is a newly discovered Epstein-Barr Virus-encoded microRNA (miRNA). We aimed to explore the role of EBV-miR-BART16 in infectious mononucleosis (IM).
Methods:
Peripheral blood lymphocyte subsets were analyzed in 30 IM and 10 healthy children by flow cytometry. MiR-BART16 and its targets were measured by real-time PCR, western blot, ELISA, and dual-luciferase assay.
Results:
Serum miR-BART16 expression was significantly higher in the IM children than that in the healthy children, and was positively correlated with EBV copy number. Receiver operating characteristic analysis revealed serum miR-BART16 could differentiate IM and healthy individuals (P=0.0041). CAND1 was targeted and downregulated by miR-BART16 in an EBV infection-dependent way.
Conclusions:
These results highlight that EBV-miR-BART16 plays an important role in regulating the expression of CAND1 to affect pediatric IM.
Insights
Epstein-Barr Virus-encoded miR-BART16 (EBV-miR-BART16) is elevated in children with infectious mononucleosis (IM). This microRNA regulates CAND1 expression, impacting pediatric IM.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Epstein-Barr Virus (EBV) is a common human herpesvirus.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression.
- EBV encodes its own miRNAs, including EBV-miR-BART16.
Purpose of the Study:
- To investigate the role of EBV-encoded miR-BART16 in pediatric infectious mononucleosis (IM).
- To determine if EBV-miR-BART16 levels correlate with IM.
- To identify targets of EBV-miR-BART16 in the context of EBV infection.
Main Methods:
- Analysis of peripheral blood lymphocyte subsets in IM patients and healthy children using flow cytometry.
- Quantification of EBV-miR-BART16 and its potential targets via real-time PCR, western blot, ELISA, and dual-luciferase assays.
- Receiver operating characteristic (ROC) analysis to assess diagnostic potential.
Main Results:
- Serum EBV-miR-BART16 levels were significantly higher in children with IM compared to healthy controls.
- Serum EBV-miR-BART16 expression positively correlated with EBV viral load.
- ROC analysis indicated serum EBV-miR-BART16 can distinguish IM patients from healthy individuals (P=0.0041).
- CAND1 was identified as a direct target of EBV-miR-BART16, with its expression downregulated in an EBV-dependent manner.
Conclusions:
- EBV-miR-BART16 plays a significant role in the pathogenesis of pediatric infectious mononucleosis.
- The study highlights EBV-miR-BART16's function in regulating CAND1 expression.
- EBV-miR-BART16 serves as a potential biomarker for diagnosing pediatric IM.
Related Concept Videos
Abnormal Proliferation
Cytomegalovirus Disease

